Abstract: Abnormalities in myocardial energy metabolism occur in association with progression to congestive heart failure. Conceivably, alterations in cardiac energy metabolism may initiate trophic responses or remodeling noted in myocardium during various disease processes. This review will explore the relationship between myocardial remodeling, contractile dysfunction, and myocardial bioenergetics. Attention will be given to data obtained from studies performed using intact animal models, which emulate congestive heart failure in humans. These data will be considered in relation to studies performed in vitro or in transgenic models. Focus will also be directed towards mechanisms of mitochondrial oxidative phosphorylation regulation (OXPHOS) and high energy phosphate transport.
INTRODUCTION
Cardiac hypertrophy occurs in response to various pathological stimuli such as pressure overload, volume overload, and ischemic injury. Remodeling associated with hypertrophy compensates for alterations in mechanical stress. This state of compensatory adaptation frequently undergoes transition to a state of contractile dysfunction characterized by signs of congestive heart failure. The precise mechanisms causing the transition from compensatory hypertrophy to contractile failure are ill defined. Some alterations in cardiac function noted during remodeling are linked to abnormalities in contractile proteins, sarcoplasmic reticulum components, and membrane receptors [1] [2] [3] . However, some deficits in mitochondrial adenosine triphosphate (ATP) production and transport can produce striated muscle dysfunction with no apparent phenotypic abnormalities in contractile proteins [4] . Additionally, abnormal coupling between energy production and utilization develops during the transition to the contractile dysfunction in certain experimental models of pathology [5] [6] [7] . Therefore, abnormalities in myocardial energy metabolism may contribute to the evolution of congestive heart failure. This review will explore the relationship between myocardial remodeling, contractile dysfunction, and myocardial bioenergetics. Particular attention will be given to data obtained from studies performed using intact animal models, which emulate congestive heart failure in humans. Focus will also be directed towards mechanisms of mitochondrial oxidative phosphorylation regulation (OXPHOS) and high energy phosphate transport, and particularly two enzyme systems, creatine kinase and the adenine nucleotide translocator. 
HIGH ENERGY PHOSPHATE METABOLISM
Developments over the past two decades have established magnetic resonance spectroscopy and imaging as powerful techniques for investigation of cardiac dynamics, morphology, and bioenergetics [8] [9] [10] . With advanced magnetic resonance imaging techniques, left ventricular (LV) systolic and diastolic volumes, LV wall thickness, ejection fraction, cardiac output and myocardial perfusion can be measured and followed nondestructively [8] . Using 31 P magnetic resonance spectroscopy (MRS), myocardial creatine kinase (CK) kinetics [10, 11] , high energy phosphate (HEP) compounds ATP and creatine phosphate (CP), and the hydrolysis product inorganic phosphate (Pi), are detected non-destructively and repetitively [8] . Accordingly, 31 P MRS can provide novel and unique insights into myocardial bioenergetics under a variety of experimental conditions. In the past, most MRS studies have been performed using perfused rodent hearts. This model system by necessity treats the cardiac muscle as biochemically homogeneous and independent of systemic physiological control mechanisms. However, in the in vivo myocardium, several aspects of myocardial bioenergetics, perfusion and systolic function are known to be transmurally non-uniform, and are importantly affected by changes in systemic hemodynamics [7, 12] . These non-uniformities are amplified during and subsequent to an ischemic insult and in the hypertrophied or failing heart. Recent studies of cardiac muscle conducted in vivo with spatially localized 31 P-MRS have permitted the examination of myocardial bioenergetics with transmural differentiation in vivo, with myocardial perfusion (microspheres) and transmural systolic function data (crystal transducer probe) acquired simultaneously.
Prior to reviewing myocardial energy metabolism in heart failure, one should be cognizant of some basics regarding the principal investigative tool, 31 P-MRS. This technique offers the ability to provide information regarding dynamic changes in absolute or relative concentration changes for specific high energy phosphates. A typical spectrum obtained from sheep myocardium is shown in (Fig.  1) . Note that the phosphorous moieties in phosphocreatine, ATP (3 peaks), and inorganic phosphate appear in the spectra. Concentrations of these phosphate moieties occur in the millimolar range and are easily detected by 31 P-MRS. The chemical shift (frequency) of the inorganic phosphate peak also permits calculation of intracellular pH. However, this peak is often obscured by resonance peaks from phosphates in 2,3 diphosphoglycerate (2,3 DPG) a component in blood. Accordingly, presence of the Pi peak depends on both species under investigation and spectroscopy technique. The 2,3 DPG concentration falls dramatically during the neonatal period in sheep, enabling detection of the intracellular inorganic phosphate (Pi) peak and calculation of intracellular pH [13] , as well as determination of Pi to ATP flux rate using saturation transfer techniques [14] (Fig. 2) .
Spatially localized methodology permits acquisition of transmurally differentiated 31 P spectra in 5 layers across the LV wall as illustrated in (Fig. 3A) from a pig heart under the basal cardiac work state. Myocardial inorganic phosphate level is too low to be detected by MRS in individual layers in normal heart under the baseline condition in certain animal models (dog, pig) or humans.
Due to inherent low concentrations (20-80µmolar) , the phosphorous moieties from myocardial free ADP are not readily measurable by any technique. However, myocardial (2) . Panel A represents control spectra during a saturation transfer experiment. B demonstrates the spectrum obtained with selective irradiation at the γ-ATP resonance frequency (arrow). The arrow in panel A marks the decoupling frequency at a region equidistant from γ-ATP-Pi, but on the high frequency side. The reference peak at 0 ppm is phosphocreatine. C represents the difference spectra (A-B). The arrow marks the difference in Pi signal at 4.9 ppm. This experiment, enabled by absence of contaminating 2,3 diphosphoglycerate in sheep blood, permits measurement of Pi to ATP flux (modified with permission from Biochemica et Biophysica Acta. This experiment also enables determination of glycolytic phosphotransfer rates.
free ADP concentration can be indirectly determined through the creatine kinase equilibrium [9, 11] . 
In following
Phosphocreatine provides the major reservoir of highenergy phosphates within the cytosol, as well as a principal mode of transport for high energy phosphate bonds to the ATP hydrolysis sites (the creatine kinase shuttle). In magnetic resonance spectroscopy studies, the phosphocreatine/ATP ratio is considered directly proportional to phosphorylation potential ([ATP]/[ADP][Pi]) [9, 11] . The creatine kinase equilibrium reaction describes the relationship between phosphocreatine (PCr) and ADP.
In addition to high energy phosphate concentrations, the forward and reverse rates for the creatine kinase reaction described in [11] can be determined using saturation transfer techniques [7, 10, 11, 15] .
Oxidative phosphorylation and mitochondrial membrane transport systems efficiently supply ATP for use by energyconsuming processes in the cardiomyocyte. Several investigators have demonstrated that the ATP production rate generally matches the overall rate of ATP hydrolysis in the mature heart in vivo (as indicated by a constant phosphorylation potential), if carbon substrate and oxygen supply to the mitochondria are ample [6, 9, 11] . The phosphorylation potential diminishes only near maximal workloads in the mature heart. The basis for this phosphorylation potential drop is an area of current investigation. Simplistically, the drop reflects an imbalance between ATP utilization and ATP supply to the contractile protein ATPases. This would imply that the phosphocreatine reservoir buffers this growing deficit through the creatine kinase reaction in order to stabilize the ATP pool. Evidence obtained from heart in vivo work to refute this notion [7, 10, 11, 15] . Oxygen serves as the principal substrate for processes leading to ATP synthesis. Thus, a limitation in oxygen supply during high-work state could restrict ATP synthesis as ATP utilization or demand increases. Disruption in the normal steady-state relationship between ATP synthesis and utilization would also be reflected as a reduction in phosphorylation potential such as observed at high cardiac work load. The possibility that the steady-state relationship between ATP synthesis and utilization is disturbed by oxygen supply limitation during high work state has been seriously challenged by studies using proton nuclear magnetic resonance to measure myoglobin saturation [6, 16] . Under work conditions that decrease phosphorylation potential in the mature dog [16] or pig [6] heart, myoglobin remains fully saturated with oxygen. These data imply that oxygen supply does not limit ATP synthesis at high work state. Furthermore, studies in vivo indicate that the phosphorylation potential reaches a new steady-state level at higher workload, thus refuting the imbalance hypothesis. Alternatively, a reset of the phosphorylation potential may be caused by a change in enzyme kinetics and mode of signal communication between mitochondrial membrane and sites of ATP hydrolysis [6, 17, 18] . This possibility will be discussed later. The steady-state relationships have been confirmed in normal mature and developing myocardium. Disruption of steady-state may occur during stress conditions in damaged or remodeled heart.
Free Energy Release Per ATP Hydrolysis
The implication of decreased phosphorylation potential at high work load should be considered with respect to free energy available for contractile work. The standard free energy of ATP hydrolysis (∆G 0 ') is directly related to phosphorylation potential by:
Pi = inorganic phosphate Therefore, near maximal work state in the mature heart, a somewhat lower amount of free energy is made available during the release of a phosphate from ATP at various ATPase sites within the myocyte [17] : ATP → ADP + Pi.
Fig. (3). [
31 P] magnetic resonance spectra from five transmural layers across the left ventricular wall of (a) a normal heart, (b) a heart with compensated left ventricular (LV) remodelling and (c) a heart with congestive heart failure under basal conditions. Spectra were scaled so that the phosphocreatine (PCr)/ATP ratios can be compared. The PCr/ATP ratio was reduced in the endocardium in LV remodelled hearts and in all transmural layers in the heart with congestive heart failure. PCr, creatine phosphate; Pi, inorganic phosphate, 2,3 DPG, 2,3 diphosphoglycerate (modified with permission from Clinical and Experimental Pharmacology and Physiology).
Pathological Conditions
The diminished release of free energy per ATP molecule at very high work states is due to the logarithmic nature of the relationship between ∆G 0 ' and phosphorylation potential. This decrease may not be problematic under conditions where the heart can maintain high levels of ATP synthesis and can perform energy efficient work. However, under stress conditions whereby oxygen or substrate supply is limited and/or mitochondrial apparatus is damaged, the decrease in phosphorylation potential can further limit free energy available to cellular processes. Hearts with pressure overload LV hypertrophy require significantly greater chemical energy to generate pump pressure in order to maintain the given cardiac output [19] [20] [21] . The abnormalities in contractile proteins and changes in myocyte geometry such as occur during remodeling create inefficiencies, which increase the energy required to achieve contractile work. Thus, the remodeled heart undergoes various stresses, which decrease energy supply, while increasing energy requirements. This change in energy balance forms the basis for the hypothesis suggesting that "energy deprivation" occurs during cardiac remodeling and exacerbates contractile failure.
Consistent with this hypothesis, hypertrophied hearts exhibit abnormalities in high energy phosphate concentrations and phosphorylation potential. Decreases in phosphocreatine/ATP (PCr/ATP) ratios occur with remodeling initiated by various stimuli and can be illustrated in different species [22] , as well as in the failing human heart under various conditions and metabolic states. [23] [24] [25] [26] [27] [28] [29] . The clinical studies demonstrate abnormalities in phosphocreatine or ATP levels, and therefore disturbances in energy metabolism. However, the investigations in humans for the most part have not specifically examined mechanisms causing these disturbances; nor have they evaluated dynamic relationships between myocardial oxygen consumption or work state and PCr/ATP.
Transmural myocardial infarction stimulates ventricular remodeling characterized by chamber dilation and hypertrophy. After a period of remodeling with hemodynamic compensation, progressive myocardial dysfunction can develop and produce overt congestive heart failure. This phenomenon has been demonstrated in pig hearts subjected to acute coronary occlusion [6, 12] . Eventually, the noninfarcted porcine myocardium exhibits increased myocyte length and volume. The severity of these alterations correlates with the size of the initiating infarct. Significant bioenergetic abnormalities occur in the porcine model in association with reduced systolic performance and left ventricular dilation contributing to increased systolic and diastolic wall stresses [6, 12] . Specifically, PCr/ATP ratio detected by transmurally localized [ 31 P]-MRS is decreased in endocardium of remodeled hearts (LVR) relative to normals, although these hearts exhibit hemodynamic compensation. The myocardial PCr/ATP ratio is further reduced in pigs exhibiting phenotypic congestive heart failure (CHF), decreasing significantly in all layers. Both myocardial ATP and total creatine levels are significantly decreased, while calculated myocardial free ADP levels increased in both LVR and CHF hearts [6, 12] . These bioenergetic abnormalities are not obviated by hyperemia induced by adenosine, implying that changes in myocardial HEP and Pi were not caused by a persistent myocardial ischemia.
The bioenergetic characteristics in the porcine infarction model correspond to data obtained from hypertrophied and failing human hearts. Clinical studies employing 31 P MRS in humans confirm that PCr/ATP ratio is reduced in hypertrophied, and decreased even further in failing human myocardium. [23, 30] Absolute ATP and PCr are also reduced in dilated cardiomyopathy and these parameters may represent more sensitive indicators of bioenergetic abnormality than PCr/ATP ratio [23, 24] . The changes in absolute ATP concentration in failing hearts are probably caused at least in part by the progressive loss of total adenine nucleotide pool (TAN) [31] . Previous studies have demonstrated that cardiac hypertrophy is accompanied by a decreased myocardial creatine phosphate to ATP ratio (PCr/ATP) and increased myocardial free ADP levels [6, 12, 15, 30, [32] [33] [34] [35] . The increase of myocardial free ADP can activate adenylate kinase that catalyzes the transfer of a phosphoryl group between two molecules of ADP to form one AMP and one ATP [22, [36] [37] [38] [39] . The increased AMP augments the conversion of AMP to adenosine [38] . Adenosine can cross the cell membrane into the interstitial space, where it is further degraded to inosine, hypoxanthine and subject to tissue washout [40] . The resulting loss of total adenine nucleotide pool (TAN) leads to a high demand for the de novo purine synthesis pathway. Loss of the TAN can result in a reduction in ATP concentration because adenine nucleotide de novo synthesis is a slow and energy costly process, as production of inosine monophosphate (IMP) from ribose-5-phosphate results in hydrolysis of six high energy phosphate bonds [40] . Recovery of the TAN pool in canine post-ischemic myocardium can take several days [36, 39, 41] . In dogs with pacing induced CHF, Shen et al [31] found that the decreased myocardial ATP concentration is related to reduction of the myocardial TAN [31] . The underlying mechanisms for this progressive depletion of the total adenine nucleotide pool during the development of CHF are not known. The interstitial purine metabolites (IPM) levels under catecholamine stimulation or during regional myocardial ischemia have been demonstrated as sensitive markers of tissue ATP depletion [42] [43] [44] .
CREATINE KINASE KINETICS
The significance as well as the mechanisms causing the changes in high energy phosphates in heart failure in animals and humans remain to be established. Reductions in steadystate phosphorylation potential at relatively low work-load might reflect disruptions in patterns of high energy phosphate flow to work sites within the cardiac myocyte. The creatine kinase (CK) system putatively plays an important role in myocardial energy metabolism by shuttling ADP rapidly to mitochondria, where ATP is generated [45, 46] , and ATP to the contractile apparatus site of utilization [45, 46] . However, the precise role of the CK system in myocardial energy metabolism remains controversial.
Several issues regarding the creatine kinase system are subjects of debate. It has not been proven that deficiencies in creatine kinase alter ATP transport enough to alter the rates of ATP utilization and synthesis and thereby reduce phosphorylation potential. Furthermore, it is yet controversial that CK deficiencies limit cardiac function.
The "shuttle hypothesis" presumes that creatine kinase facilitates diffusion or transfer of high energy phosphates through the cytosol. The hypothesis emphasizes the higher diffusion capacity between mitochondria and contractile apparatus of creatine (Cr) compared with ADP and phosphocreatine compared to ATP. There are also suggestions that mitochondrial creatine kinase facilitates exchange of the adenylate nucleosides across the mitochondrial membrane. To limit energy utilization one would expect the creatine kinase flux rate to approximate or slightly exceed the rate of ATP synthesis, assuming that ATP synthesis rate is equivalent to ATP production rate. Therefore, any deficiency in the creatine kinase shuttle would decrease ATP transport, reduce ATPase activity at the myofibrils, and limit contractile function. Results of studies performed in heart in vivo have challenged the importance of this shuttle mechanism in normal myocardium. Studies in several species in vivo show that creatine kinase (CK) flux operates near equilibrium at substantially higher rates (10-20 fold) than the ATP synthesis rate [47] . Several investigators found that myocardial creatine kinase flux does not increase during substantial elevations in ATP synthesis [6, 9, 10] , implying that ATP transport does not increase through the creatine kinase shuttle mechanism during inotropic stimulation. In sheep, the newborn heart exhibits substantially lower levels of total creatine kinase activity (62%) than occur in the mature counterpart. This relatively low level of CK activity in the newborn heart produces lower CK flux, and a paradoxical decrease in flux during elevation in ATP synthesis rate [10] . Nevertheless, no restriction in myocardial oxygen consumption or contractile function results, as CK flux persists several-fold higher than ATP synthesis rate. Thus, these experimental data imply that substantial deficits in creatine kinase activity do not limit ATP transport or contractile function in the normal aerobic heart. However, creatine kinase phosphotransfer may define limits of maximal ATP synthesis in specific situations. Myocardial creatine kinase forward flux decreases during remodelling in the porcine heart after infarction (Figs 4 and  5 ). An alteration in flux at baseline work-state occurs in response to various trophic stimuli, including infarction [6] and aortic stenosis [15, 48] . The severity of the reductions in creatine kinase flux is exacerbated during the transition from hemodynamic compensation to overt congestive heart failure. In the pig postinfarction model, the ratio of creatine kinase flux to ATP synthesis rate at the maximum obtainable workload obtained by dobutamine infusion falls to similar levels in normal and remodelled myocardium, approximatelỹ 3:1, assuming 3 molecules ADP phosphorylated per molecules oxygen consumed 14 . Failing hearts operating with a baseline creatine kinase flux to ATP synthesis ratio approximating (3:1) were unable to increase contractile function or myocardial oxygen consumption with a similar dobutamine protocol. Therefore it is possible that the ratio of the CK flux rate to the rate of ATP synthesis approximating 3:1 or 4:1 reflects the threshold necessary for maintaining optimal cross-bridge function. These calculations are dependent on the approximation of P:O ratio. Structural modifications in the mitochondrial membrane after hypoxic insult may have reduced P:O ratio, so that ATP synthesis rates in failing myocardium were overestimated [49, 50] , and limiting CK flux/ATP synthesis may be somewhat higher.
Creatine kinase flux in these porcine models relates directly to the level of the mitochondrial creatine kinase isoform (CK-ScMt). This relationship supports the intriguing hypothesis, that creatine kinase abnormalities in specific cellular compartments can limit contractile function. The creatine kinase system consists of distinct operating components localized within specific cellular compartments. Five distinct creatine kinase isoforms have been identified. The subunits M (muscle) and B (brain) form dimers producing three functional isozymes: MM, MB and BB. CK-MM, the predominant isozyme in mature myocardium, is localized within the cytosol near the thick filaments of the contractile apparatus, thereby allowing interaction with myosin ATPase [51, 52] ; CK-MB and CK-BB exist mainly in fetal myocardium during developmental transition period. Two mitochondrial isozymes exist: ubiquitous (CK-uMt) and sarcomeric mitochondrial isozyme (CK-ScMt) [45, 46, 51] Ck-uMt is not expressed in heart [53] . CK-Sc-Mt differs biochemically and immunologically from the cytosolic forms and can form dimers and octomers [54, 55] . The CK-ScMt is located in the inner mitochondrial membrane and functionally couples with adenine nucleotide translocator (ANT) to promote adenylate exchange. Fractional activity for CK-ScMt varies substantially across species representing near 40% total CK activity in mice [56] , but only about 10% in humans and larger species [57] .
Studies performed in vitro confirm that creatine kinase abnormalities occur in subcellular compartments from rat heart failing from chronic pressure overload [58] . Reductions in myobril maximal force and alterations in cross-bridge kinetics, as well as abnormalities in Ca++ loading at the sarcoplasmic reticulum occur in association with decreased Ck-MM activity. Additionally, heart failure induced reduction in maximal oxidative capacity occurs in association with marked reduction in CK-ScMt. However, subcellular abnormalities are broad in scope and therefore a causal relationship with CK deficits has not been established in the heart failure models.
Further study testing the compartmental hypothesis has been performed using mice with null mutations for genes expressing various creatine kinase isoforms. Contractile performance of isolated perfused hearts is unchanged for low to moderate workloads in mice with the single knockout mutation (M-CK-/-) or the double knockout (M-CK/ScMt-CK) [33] . The double knockout mutation did produce changes in kinetics of cardiac energy metabolism including a substantial decrease in free energy of ATP hydrolysis and an increase in cytosolic ADP accumulation during change in workload. The alterations in cardiac energetics have recently been confirmed in a single knockout mutation of for ScMt-CK, which also exhibits no difference in contractile function during isolated perfused heart protocols [56] .
Data obtained using these mouse mutations appear to conflict with observations taken from the porcine model, and challenge the concept that creatine kinase abnormalities in general or in compartmental fashion influences cardiac contractile performance during heart failure. However, the data from the isolated perfused transgenic mouse hearts should be considered in the context of the experimental model and its limitations. The heart does not near maximal work capacity during isolated perfusion either in Langendorff or working heart model. Conceivably, contractile dysfunction would be detected under more physiological conditions such as occur in situ with or without exercise. Interestingly, a paucity of exercise performance data exists for these creatine kinase deficient mice. These mice do exhibit abnormalities in skeletal muscle function, which might hinder interpretation of cardiac performance data during treadmill testing [59] .
As noted, the studies in creatine kinase deficient mice have challenged concepts relating this enzyme's kinetics to contractile function under fully aerobic conditions. Investigators have for the most part evaluated importance and tenability of the creatine kinase shuttle mechanism. Alternatively, the creatine kinase system functions principally as an energy and pH buffer for the cell during oxygen deprivations conditions [60] [61] [62] . This system preserves myocardial ATP and intracellular pH for variable time periods in situ, depending on the form and severity of hypoxic insult. Further studies of creatine kinase deficient mice are necessary to evaluate their response to oxygen deprivation conditions.
ADENYLATE KINASE
As noted previously, adenylate kinase catalyzes reversible phosphotransfer between two ADP molecules to form ATP and AMP. Thus, changes in flux through this enzyme could provide some phosphate transport accommodation for creatine kinase deficiencies [63] . Adenylate kinase compartmentalized with enzymes responsible for ATP hydrolysis would increase ATP and AMP production at those specific sites and reduce the requirement for high energy phosphate transport from the mitochondria. During normoxic conditions, hearts with an adenylate kinase (AK1) gene knockout do not demonstrate abnormal function or high energy phosphate metabolism. However, these hearts exhibit blunted high energy phosphate transport and contractile responses to metabolic stresses such as hypoxia or ischemia [64] [65] [66] . Other experimental data indicate that phosphotransfer through adenylate kinase, generally considered relatively minor under normal conditions, increases in importance during heart failure [63] . Phosphotransfer accommodation through adenylate kinase would increase myocardial purine depletion under normal or high flow conditions as mentioned previously. Fig. (4) . Typical 31 P magnetic resonance saturation transfer spectra from a normal heart (Top panel) and a heart with congestive heart failure (bottom panel) under basal conditions. This experiment was directed towards measurement of PCr to ATP flux. A DANTE pulse sequence consisting of a short hard pulse train was used to saturate γ-ATP resonance (Arrow, B). This experiment differs from that illustrated in Figure  2 in that the control spectra (A) were acquired by setting the saturation pulse frequency on the opposite side of the PCr resonance with a frequency difference identical to that of PCr and ATP. The relative change of PCr resonance intensity between the saturated (B) and control spectra (A) is proportional to the forward rate constant (k f ) of CK. The forward rate constant (k f ) of CK is significantly decreased in hearts with CHF (modified with permission from American Journal of Physiology Heart and Circulatory Physiology).
GLYCOLYTIC PHOSPHOTRANSFER
Magnetic resonance phosphorous saturation transfer studies performed in perfused hearts have demonstrated that glycolytic reactions contribute to unidirectional inorganic phosphate to ATP flux [67] [68] [69] . The glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate kinase, catalyze their reactions in tandem at high rates in both forward and reverse directions. Studies in sheep heart confirm that these reactions operate at high rates and near equilibrium under conditions in vivo, which exhibit the expected low rates of glucose utilization relative to other substrates (Fig. 2) [14] Furthermore, perturbations to increase ATP synthesis such as epinephrine stimulation do not alter glycolytic contribution to ATP synthesis. As noted in prior sections, the saturation transfer experiment does necessarily deal with compartmental issues. Conceivably, glycolytic phosphotransfer provides an important source of ATP synthesis within specific subcompartments, as postulated by some investigators [70] . Additionally, net glucose oxidation increases during heart failure in vivo. [71] The accompanying increase in glycolysis may alter the equilibrium for the glycolytic phosphotransfer enzymes, and thereby promote their relative contribution to net ATP synthesis. Nevertheless, as the glycolytic phosphotransfer reactions occur at a high bidirectional rate, their contribution to net ATP synthesis under normal conditions in vivo remains unproven.
ADENINE NUCLEOTIDE TRANSLOCATOR
The adenine nucleotide translocator (ANT) spans the inner mitochondrial membrane. This protein is the only enzyme known to exchange cytosolic ADP for mitochondrial ATP [72] . Thus deficits in either quantity or function of this enzyme would severely limit adenine nucleoside transport in the cardiomyocyte. Recently, ANT has been shown to involve ScMit-CK and porin in formation of the permeability transition pore, which plays a role in regulation of programmed cell death (apoptosis). Therefore, the exchanger serves as an important structural component of the inner mitochondrial membrane, possibly preserving membrane integrity and cell viability. The multiple critical functions of this protein suggest that ANT participates in the pathogenesis of heart failure and myocardial remodelling [5, 73] .
Exchange of cytosolic ADP for ATP across the mitochondrial membrane represents the principal function for ANT [74] . ADP/ATP exchange occurs in conjunction with proton translocation through the mitochondrial F1-F0 ATPase, a protein complex closely associated with ANT in the inner mitochondrial membrane. These two processes ultimately result in phosphorylation of ADP using energy derived from the membrane electrochemical potential [75, 76] . During increases in cardiac work, signal transduction occurs between the cytosolic energy utilizing sites and oxidative phosphorylation sites within the mitochondria. The heart demonstrates rapid signal transduction between these processes in order to maintain a steady supply of high energy phosphates, and to preserve energy stores. It is probable that several modes of signal communication exist that might vary according to work state [17, 76] . Normally, ANT is highly abundant within the mitochondrial membrane, thereby providing ample exchange sites for transfer of ADP as substrate for the phosphorylation processes. Efficiency can be measured in vitro by incubating isolated mitochondria with the specific ANT inhibitor, carboxyatractylate, during state III or ADP stimulated respiration. Titration of these mitochondria with increasing carboxyatractylate concentrations indicates that ANT normally does not limit or control respiration [77] [78] [79] [80] . Theoretically, if exchange sites are dramatically reduced in number, then ADP availability might limit the respiration rate. Under conditions of ADP-ATP exchange limitation, ADP through its interaction at the nucleoside exchanger would regulate respiration following a simple kinetic model [81] . Elevation in free cytosolic ADP produced by ATP hydrolysis at work sites would then drive exchange for ATP produced within the mitochondrial membrane and stimulate oxidative phosphorylation. Most studies in mature heart in vivo have demonstrated that [ADP] is constant over a moderate range of oxygen consumption rates [9 ,11,17] . These findings in several mammalian species indicate that ADP and thus ANT play negligible roles in regulating oxidative phosphorylation in mature myocardium at moderate workloads. As noted previously, small changes in ADP have been detected at very high work-state implying that ANT might control at those higher levels [9, 17, 82] . In contrast, ADP increases substantially during oxygen consumption elevations in the newborn heart in vivo [11, 83] . Analyses using sigmoid saturation kinetics indicate that ADP does not appear to regulate respiration in the mature heart. However, respiratory control appears to follow a simple Michaelis-Menten pattern in the newborn heart implying that ADP and thus ANT control oxidative phosphorylation rate. One might presume that the newborn mitochondria require an elevation in ADP to drive respiration because of limitations in number or quality of ANT exchanger sites. In support of this hypothesis, the developmental transition from the ADP-dependent to non-ADP dependent respiratory control occurs concurrently with accumulation of ANT within the mitochondrial membrane [80, 81] .
Respiratory kinetic patterns observed in hearts with specific types of cardiomyopathy resemble those apparent in the immature heart in that elevated levels of ADP accompany increases in myocardial oxygen consumption at moderate work levels [5, 7, 83] . In the porcine postinfarction model the transition to ADP-dependent mode of myocardial respiratory control coincides with the progression to congestive heart failure. Hearts with compensated left ventricular hypertrophy do not exhibit ADP-dependent respiratory kinetics. Reiteration of immature patterns of respiratory control in failing hearts coincides with loss of ANT in the mitochondrial membrane [5, 81] , suggesting a mechanism for altered energy metabolism. However, the relationship between myocardial energetics, ANT, and myocardial remodelling remains somewhat vague.
This relationship has been evaluated in an extreme example of ANT deficiency.
Cardiac mitochondria from homozygous ANT1 deficient mice express some ANT2, but exhibit markedly decreased total levels of the protein. [84] Accordingly, these mitochondria achieve lower rates of state III or ADPstimulated respiration than normal littermates. These mice have not been subjected to more sophisticated 31 P MR analyses of respiratory kinetics. However, the hearts from ANT1 deficient mice develop progressive myocardial hypertrophy and left ventricular wall thickening implying that this mitochondrial protein deficit contributes to myocardial remodeling seen in hypertrophic diseases [33] .
Questions remain as to whether alterations in ANT during heart failure are nuclear mediated. Deficiencies in ANT protein expression in failing heart occur concurrently with reductions in expression for various components of the F1-F0ATPase [85] . This coordinated downregulation implies that alterations in respiratory kinetics and ATP synthesis capacity, as well as developmental accumulation of ANT, are all regulated at the transcriptional level. Three distinct nuclear encoded ANT isoforms (ANT1, ANT2, ANT3), correspond to similar isoforms in many mammalian species. These isoforms demonstrate tissue specificity, and their expression is sensitive to the particular cell's physiological conditions [86] . Transcript levels respond to cellular demands by varying the rate of isoform mRNA synthesis and/or stability [87] . Cardiac muscle expresses all three isoforms, although ANT1 gene expression predominates. Transcriptional regulation of ANT1 in myogenic mouse cells occurs through a muscle-specific positive promoter element (OXBOX), as well as a tissue ubiquitous (REBOX) region, which overlaps OXBOX [86] . Binding of REBOX factors was found to be sensitive to NADH and thyroid hormones, T4 and T3, suggesting that ANT1 regulation can be modulated by these environmental factors. The muscle specific promoter element appears to be shared by the ATP synthase β subunit, and occurs upstream of the putative transcription start sites for each gene. Sharing of this unit indicates that these genes are coordinately expressed. Accordingly, steady-state mRNA expression of both these genes increases during transition from fetal to mature stage in hearts of at least two species, ovine and rabbit [81, 88] .
The signals, which alter expression of these genes during cardiac maturation and possibly during transition to heart failure require further clarification. As noted thyroid hormone has been implicated as a regulator of ANT transcription. Sheep thyroidectomized immediately after birth demonstrate marked decreases in steady-state expression for all three ANT isoforms, but show no deficit in βF1-ATPase expression [83] . This implies that thyroid hormone specifically regulates ANT through mechanisms that do not involve the shared promoter sites. The thyroidectomy induced alterations in ANT isoform expression coordinate with reductions in protein expression and delay in transition to non-ADP dependent type respiratory control. Several investigators have recently shown that thyroid hormone metabolism is perturbed during congestive heart failure [89, 90] , and CHF patients exhibit relatively low circulating T3 levels despite normal thyroxine (T4) and TSH levels. These observations imply that thyroid hormone could play a significant role in regulation of myocardial respiration during heart failure. Certain other stimuli during heart failure such as myocardial stretch have been linked to signaling and expression for various mitochondrial proteins, and may play a role in transcriptional modulation of ANT.
METABOLIC SIGNALING AND COORDINATION WITH KATP
Alterations in high energy transport may effect metabolic signaling for key proteins and provide the mechanistic link between energy metabolism and maladaptive cardiac remodeling. KATP channel signaling provides an example of probable linkage between cellular homeostasis and phosphotransfer. [91] These channels effect electrical activity and regulate diverse cellular functions. Mutations in specific KATP components such as the regulatory cardiac sulfonlylurea (SUR2A) subunit have been identified in patients with dilated cardiomyopathy and may provide a mechanism for channelopathy. [92] Metabolic sensing of the KATP channel occurs through modulation of ATP sensitivity of the pore forming Kir6.2 subunit by SUR2A, which harbors intrinsic ATPase activity. [93] There appears to be an intimate relationship between SUR2A ATPase activity and phosphotransfer systems, particularly creatine kinase and adenylate kinase. Disruption in KATP channel activity occurs in transgenic mice exhibiting mutations in these phosphotransfer systems, which alter ATP or ADP concentration at the local compartmental level. Interaction between KATP and phosphotransfer systems at the compartmental level is difficult to confirm in heart in vivo. In the porcine model KATP inhibition with glibenamide does interfere with modulation of myocardial respiration that normally occurs during hypoperfusion. [94] This finding in vivo supports the hypothesis that KATP activity coordinates with phosphotransfer; and prolonged disruption of these systems would lead to contractile dysfunction and heart failure.
SUMMARY
High energy phosphate transport abnormalities occur in conjunction with heart failure and cardiac remodeling. In an extreme example such as in the ANT1 deficient mouse, abnormalities in a protein participating in cellular energy transport induce phenotypic changes myocyte architecture and organization. Disruption in phosphotransfer mechanisms effects cellular homeostasis and metabolic signaling for multiple cellular processes. These abnormalities may be obviated by therapy directed at transcriptional regulation of mitochondrial proteins, such as thyroid hormone supplementation.
Certainly, substantial opportunity continues for further investigation in this area.
